Earnings History Data for Century Therapeutics (IPSC) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Century Therapeutics
Century Therapeutics Inc. is a cell therapy company. It involved in developing induced pluripotent stem cell -derived cell therapies in immuno-oncology. Century Therapeutics Inc. is based in PHILADELPHIA.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05-11-2024 | PM | IPSC | Century Therapeutics | 107.00 | -0.37 | -0.46 | 0.00 | Century Therapeutics Non-GAAP EPS of -$0.37 beats by $0.08, revenue of $0.8M beats by $0.25M [11/5/2024 9:59 AM] |
1.35 | 0.09 (7.13%) |
0.0 | 0.0 (0.00%) |
1.14 - 5.51 | 532,220 | 440,000 | 0 | ||
|
||||||||||||||||||
| 08-08-2024 | PM | IPSC | Century Therapeutics | 151.00 | -0.38 | -0.50 | 0.00 | Century Therapeutics GAAP EPS of -$0.38, revenue of $0.8M [8/8/2024 8:14 AM] |
1.80 | 0.07 (4.05%) |
0.0 | 0.0 (0.00%) |
1.28 - 5.51 | 295,042 | 230,000 | 0 | ||
| 14-03-2024 | PM | IPSC | Century Therapeutics | 284.00 | -0.49 | -0.56 | 0.00 | Century Therapeutics GAAP EPS of -$2.30, revenue of $2.2M [3/14/2024 11:45 AM] |
4.50 | -0.36 (-7.30%) |
0.0 | 0.0 (0.00%) |
1.28 - 5.51 | 125,787 | 150,000 | 0 | ||
| 09-08-2023 | PM | IPSC | Century Therapeutics | 176.00 | -0.56 | -0.54 | 0.00 | Century Therapeutics GAAP EPS of -$0.56, revenue of $0.09M [8/9/2023 12:25 PM] |
2.83 | -0.07 (-2.41%) |
0.0 | 0.0 (0.00%) |
2.81 - 14.00 | 47,627 | 50,000 | 0 | ||
| 11-05-2023 | PM | IPSC | Century Therapeutics | 197.00 | -0.53 | -0.53 | 0.00 | Century Therapeutics GAAP EPS of -$0.53, revenue of $1.72M [5/11/2023 9:56 AM] |
3.37 | -0.06 (-1.75%) |
0.0 | 0.0 (0.00%) |
2.81 - 14.00 | 45,898 | 70,000 | 0 | ||
| 10-11-2022 | PM | 7:30 AM ET (Nov 11) |
IPSC | Century Therapeutics, Inc. | 605.89 | -0.53 | -0.59 | -0.48 | Century Therapeutics GAAP EPS of -$0.53 beats by $0.06, revenue of $2.22M beats by $0.98M [11/10/2022 9:19 AM] |
11.53 | 1.47 (14.61%) |
10.06 | 0.0 (0.00%) |
7.32 - 21.84 | 180,062 | 60,000 | 280 | |
| 16-05-2022 | PM | 7:30 AM ET (May 16) |
IPSC | Century Therapeutics | 474.00 | -0.66 | -0.45 | 0.00 | Century Therapeutics GAAP EPS of -$0.66 misses by $0.20, revenue of $1.06M misses by $5.61M [5/16/2022 9:39 AM] |
8.72 | 0.65 (8.05%) |
8.07 | 0.0 (0.00%) |
7.32 - 32.90 | 65,481 | 130,000 | 1,668 | |
| 17-03-2022 | PM | IPSC | Century Therapeutics, Inc. | 752.18 | -0.24 | -0.46 | 0.00 | Century Therapeutics GAAP EPS of -$2.96 beats by $0.38 [3/17/2022 9:09 AM] |
12.95 | -0.24 (-1.82%) |
13.19 | 0.0 (0.00%) |
10.96 - 32.90 | 103,686 | 113,065 | 521 | ||
| 10-11-2021 | PM | 8:00 AM ET (Nov 10) |
IPSC | Century Therapeutics | 1,164 | -0.48 | -0.40 | 0.00 | Century Therapeutics EPS misses by $0.08 [11/10/2021 9:07 AM] |
21.00 | -0.39 (-1.82%) |
0.0 | 0.0 (0.00%) |
16.29 - 32.90 | 88,490 | 70,000 | 0 | |